Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine

Clinical trial NCT02828020 · COMPLETED

Trial details

NCT number: NCT02828020
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Migraine, With or Without Aura

Start date: 2016-07-22
Primary completion: 2017-12-13
Enrollment: 1672

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.